Retraction: A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department (International Journal of Neuropsychopharmacology (2011) 14 (1127-1131) DOI: 10.1017/S1461145711000629);A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department

International Journal of Neuropsychopharmacology

Volumn 14, Issue 8, 2011, Pages 1127-1131

  Larkin, Gregory Luke ^a   Beautrais, Annette L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Depression; emergency department; ketamine; MADRS; suicide ideation

Indexed keywords

KETAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; EMERGENCY WARD; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; LOW DRUG DOSE; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PATIENT MONITORING; PRIORITY JOURNAL; REMISSION; SINGLE DRUG DOSE; SUICIDAL IDEATION; TREATMENT RESPONSE;

EID: 80053025475     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyx035     Document Type: Erratum

References (19)

1. aan het Rot M, Collins KA, Murrough JW, Perez AM, et al. (2010). Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biological Psychiatry, 67, 139-145.
2. Beck AT, Steer RA, Ranieri WF (1988). Scale for suicide ideation: psychometric properties of a self-report version. Journal of Clinical Psychology 44, 499-505.
3. Berman RM, Cappiello A, Anand A, Oren DA, et al. (2000). Antidepressant effects of ketamine in depressed patients. Biological Psychiatry 47, 351-354. (Pubitemid 30109248)
4. Diaz Granados N, Ibrahim L, Brutsche NE, Newberg A, et al. (2010). A randomized add-on trial of an N-methyl-D aspartate antagonist in treatment-resistant bipolar depression. Archives of General Psychiatry 67, 793-802.
5. Frueh BC, Dalton ME, Johnson MR, Grubaugh AL, et al. (2000). Trauma within the psychiatric setting: conceptual framework, research directions, and policy implications. Administration and Policy in Mental Health 28, 147-154. (Pubitemid 32059688)
6. Krystal JH (2010). N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants. Commentary. Archives of General Psychiatry 67, 1110-1111.
7. Li N, Lee BY, Liu R-J, Banasr M, et al. (2010). mTOR dependent synaptogenesis is required for the rapid antidepressant actions of NMDA antagonists. Science 329, 959-964.
8. Mathew SJ, Murrough JW, Aan Het RotM,Collins KA, et al. (2009). Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial. International Journal of Neuropsychopharmacology. Published online: 17 March 2009. doi:10.1017/S1461145709000169.
9. Meltzer HY, Alphs L, Green AI, Altamura AC, et al. (2003). Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Archives of General Psychiatry 60, 82-91. (Pubitemid 36070868)
10. Montgomery SA, Asberg M (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134, 382-389. (Pubitemid 9136500)
11. Nestler EJ, Carlezon JWA (2006). The mesolimbic dopamine reward circuit in depression. Biological Psychiatry 59, 1151-1159. (Pubitemid 44192421)
12. Overall JE, Gorham DR (1962). The brief psychiatric rating scale. Psychological Reports 10, 799-812.
13. Phelps L, Brutsche N, Moral J, Luckenbaugh DA, et al. (2009). Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist. Biological Psychiatry 65, 181-184.
14. Price R, Nock M, Charney D, Mathew S (2009). Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biological Psychiatry 66, 522-526.
15. Sharma V (2001). The effect of electroconvulsive therapy on suicide risk in patients with mood disorders. Canadian Journal of Psychiatry 46, 704-709. (Pubitemid 33127085)
16. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, et al. (1998). The Mini-International Neuropsychiatric Interview (M. I. N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59 (Suppl. 20), 22-33. (Pubitemid 29001829)
17. Tondo L, Baldessarini RJ (2009). Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients. Epidemiologia e Psichiatria Sociale 18, 179-183.
18. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978). A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry 133, 429-435. (Pubitemid 9006756)
19. Zarate CA, Singh JB, Carlson PJ, Brutsche NE, et al. (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry 63, 856-864. (Pubitemid 44188478)